Publication: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier BV